Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Inflammatory Bowel Disease
•
Gastroenterology
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
What is your approach to managing ILD associated with inflammatory bowel disease?
Related Questions
How would you approach management of a patient with seropositive RA and UIP-ILD, with concern for active lung disease?
What is your approach to treatment in a patient with radiographic UIP but pathologic evidence of both fibrotic NSIP and UIP?
How do you approach the treatment of Crohn's colitis in the setting of immunosuppression for liver transplant?
When and how should we use biomarkers (i.e., CRP, stool calprotectin, mAb levels) to guide or optimize medical management of Crohn’s disease or ulcerative colitis?
Would you consider adding or switching to pirfenidone for a patient with progressing UIP (based on imaging and PFTs) who is currently on nintedanib?
What is the duration of steroids that you prescribe for organizing pneumonia?
How would you manage a patient with Crohn's disease on a biologic and presents with non-bloody diarrhea, normal-appearing mucosa on sigmoidoscopy but severe colitis on biopsy with a positive CMV stain?
How do you approach a patient with sarcoidosis who cannot tolerate steroids and who is developing ILD?
Do you seek pathologic confirmation before proceeding with empiric immunosuppressive therapy in symptomatic patients with radiographic NSIP?
What is your approach to evaluating amiodarone induced interstitial pneumonitis?
